When XDx yesterday filed to raise up to $86.3 million in an IPO, the Brisbane, Calif., company joined just a handful of similar molecular-diagnostic companies to test the public markets. XDx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results